B, L., YC, K., MR, S., ATH, W., & HS, H. (2021). In vivo Pharmacokinetic and Anticancer Studies of HH-N25, a Selective Inhibitor of Topoisomerase I, and Hormonal Signaling for Treating Breast Cancer. Dove Medical Press.
Chicago Style (17th ed.) CitationB, Lawal, Kuo YC, Sumitra MR, Wu ATH, and Huang HS. In Vivo Pharmacokinetic and Anticancer Studies of HH-N25, a Selective Inhibitor of Topoisomerase I, and Hormonal Signaling for Treating Breast Cancer. Dove Medical Press, 2021.
MLA (8th ed.) CitationB, Lawal, et al. In Vivo Pharmacokinetic and Anticancer Studies of HH-N25, a Selective Inhibitor of Topoisomerase I, and Hormonal Signaling for Treating Breast Cancer. Dove Medical Press, 2021.
Warning: These citations may not always be 100% accurate.